Tags

Type your tag names separated by a space and hit enter

Preferences for a COVID-19 vaccine in Australia.
Vaccine. 2021 01 15; 39(3):473-479.V

Abstract

In absence of a COVID-19 vaccine, testing, contact tracing and social restrictions are among the most powerful strategies adopted around the world to slow down the spread of the pandemic. Citizens of most countries are suffering major physical, psychological and economic distress. At this stage, a safe and effective COVID-19 vaccine is the most sustainable option to manage the current pandemic. However, vaccine hesitancy by even a small subset of the population can undermine the success of this strategy. The objective of this research is to investigate the vaccine characteristics that matter the most to Australian citizens and to explore the potential uptake of a COVID-19 vaccine in Australia. Through a stated preference experiment, preferences towards a COVID-19 vaccine of 2136 residents of the Australian states and territories were collected and analysed via a latent class model. Results show that preferences for mild adverse cases, mode of administration, location of administration, price and effectiveness are heterogeneous. Conversely, preferences for immediacy and severe reactions are homogeneous, with respondents preferring a shorter period until vaccine is available and lower instances of severe side effects. The expected uptake of the vaccine is estimated under three different scenarios, with the value of 86% obtained for an average scenario. By calculating individual preferences, the willingness to pay is estimated for immediacy, effectiveness, mild and severe side effects.

Authors+Show Affiliations

Centre for Business Intelligence and Data Analytics, Business School, University of Technology Sydney, 14/28 Ultimo Rd, Ultimo, NSW 2007, Australia. Electronic address: antonio.borriello@uts.edu.au.Centre for Business Intelligence and Data Analytics, Business School, University of Technology Sydney, 14/28 Ultimo Rd, Ultimo, NSW 2007, Australia.Centre for Business Intelligence and Data Analytics, Business School, University of Technology Sydney, 14/28 Ultimo Rd, Ultimo, NSW 2007, Australia.Centre for Business Intelligence and Data Analytics, Business School, University of Technology Sydney, 14/28 Ultimo Rd, Ultimo, NSW 2007, Australia.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

33358265

Citation

Borriello, Antonio, et al. "Preferences for a COVID-19 Vaccine in Australia." Vaccine, vol. 39, no. 3, 2021, pp. 473-479.
Borriello A, Master D, Pellegrini A, et al. Preferences for a COVID-19 vaccine in Australia. Vaccine. 2021;39(3):473-479.
Borriello, A., Master, D., Pellegrini, A., & Rose, J. M. (2021). Preferences for a COVID-19 vaccine in Australia. Vaccine, 39(3), 473-479. https://doi.org/10.1016/j.vaccine.2020.12.032
Borriello A, et al. Preferences for a COVID-19 Vaccine in Australia. Vaccine. 2021 01 15;39(3):473-479. PubMed PMID: 33358265.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Preferences for a COVID-19 vaccine in Australia. AU - Borriello,Antonio, AU - Master,Daniel, AU - Pellegrini,Andrea, AU - Rose,John M, Y1 - 2020/12/16/ PY - 2020/10/09/received PY - 2020/12/07/revised PY - 2020/12/10/accepted PY - 2020/12/29/pubmed PY - 2021/1/14/medline PY - 2020/12/28/entrez KW - Acceptance KW - COVID-19 KW - Uptake KW - Vaccine KW - Willingness to pay SP - 473 EP - 479 JF - Vaccine JO - Vaccine VL - 39 IS - 3 N2 - In absence of a COVID-19 vaccine, testing, contact tracing and social restrictions are among the most powerful strategies adopted around the world to slow down the spread of the pandemic. Citizens of most countries are suffering major physical, psychological and economic distress. At this stage, a safe and effective COVID-19 vaccine is the most sustainable option to manage the current pandemic. However, vaccine hesitancy by even a small subset of the population can undermine the success of this strategy. The objective of this research is to investigate the vaccine characteristics that matter the most to Australian citizens and to explore the potential uptake of a COVID-19 vaccine in Australia. Through a stated preference experiment, preferences towards a COVID-19 vaccine of 2136 residents of the Australian states and territories were collected and analysed via a latent class model. Results show that preferences for mild adverse cases, mode of administration, location of administration, price and effectiveness are heterogeneous. Conversely, preferences for immediacy and severe reactions are homogeneous, with respondents preferring a shorter period until vaccine is available and lower instances of severe side effects. The expected uptake of the vaccine is estimated under three different scenarios, with the value of 86% obtained for an average scenario. By calculating individual preferences, the willingness to pay is estimated for immediacy, effectiveness, mild and severe side effects. SN - 1873-2518 UR - https://www.unboundmedicine.com/medline/citation/33358265/Preferences_for_a_COVID_19_vaccine_in_Australia_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0264-410X(20)31599-1 DB - PRIME DP - Unbound Medicine ER -